Almost simultaneously, another study revealed the distinct expression of a panel of miRNAs in a comparison between ERα-positive and -negative breast cancer cell lines and primary tumors, using a custom miRNA microarray platform containing 515 miRNAs (48). This evidence concerns the gene ESR1 and breast cancer.